A Low Serum Calcium-to-Potassium Ratio Predicts Postpartum Venous Thromboembolism Risk: Mediation by Hemoglobin and D-Dimer in a Multicenter Cohort

Qian Li , Guofu Zhang , Xiating Li , Huafang Wang , Jun Deng , Zhipeng Cheng , Fengjuan Fan , Shi Chen , De Li , Liang V. Tang , Yu Hu

MedComm ›› 2026, Vol. 7 ›› Issue (7) : e70843

PDF (1683KB)
MedComm ›› 2026, Vol. 7 ›› Issue (7) :e70843 DOI: 10.1002/mco2.70843
ORIGINAL ARTICLE
A Low Serum Calcium-to-Potassium Ratio Predicts Postpartum Venous Thromboembolism Risk: Mediation by Hemoglobin and D-Dimer in a Multicenter Cohort
Author information +
History +
PDF (1683KB)

Abstract

Postpartum venous thromboembolism (VTE) is a serious complication, and electrolytes may play a role in coagulation homeostasis, but their associations with postpartum VTE remain unclear. A total of 25,792 pregnant women from Chinese multicenter cohort between January 2017 and December 2024 were included, and the occurrences of postpartum VTE within 6 weeks after delivery were followed. Here, we show that dysregulated perinatal electrolyte profiles and a reduced serum calcium (Ca)/potassium (K) ratio are novel and independent risk factors for postpartum VTE, with hemoglobin and D-dimer levels mediating such associations. Restricted cubic spline analyses showed that low serum Ca (overall association p = 0.032) and high serum K (overall association p = 0.036) were associated with increased postpartum VTE risk. Serum magnesium exhibited a nonlinear inverse U-shaped association with VTE risk (nonlinear p = 0.021). Low serum Ca/K ratio was linked to elevated VTE risk (overall association p = 0.004), with a nonlinear relationship (nonlinear p = 0.042) and an inflection point at 0.55. Notably, a serum Ca/K ratio below 0.55 is a promising new biomarker for predicting the risk of postpartum VTE. Mediation analyses suggested that the protective effect of a higher Ca/K ratio might be partially explained by its association with higher hemoglobin levels (34.7% mediation, p = 0.036) and lower D-dimer levels (4.6% mediation, p = 0.018). This study suggests that strategies aimed at optimizing perinatal electrolyte balance and the monitoring and management of anemia may help reduce the burden of postpartum VTE.

Keywords

electrolyte / hemoglobin / postpartum / pregnant women / venous thromboembolism

Cite this article

Download citation ▾
Qian Li, Guofu Zhang, Xiating Li, Huafang Wang, Jun Deng, Zhipeng Cheng, Fengjuan Fan, Shi Chen, De Li, Liang V. Tang, Yu Hu. A Low Serum Calcium-to-Potassium Ratio Predicts Postpartum Venous Thromboembolism Risk: Mediation by Hemoglobin and D-Dimer in a Multicenter Cohort. MedComm, 2026, 7 (7) : e70843 DOI:10.1002/mco2.70843

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

J. A. Heit, “Epidemiology of Venous Thromboembolism,” Nature Reviews Cardiology 12 (2015): 464–474.

[2]

M. Blondon, B. S. Quon, L. B. Harrington, H. Bounameaux, and N. L. Smith, “Association Between Newborn Birth Weight and the Risk of Postpartum Maternal Venous Thromboembolism: A Population-Based Case-Control Study,” Circulation 131 (2015): 1471–1476.

[3]

K. Meng, X. Hu, X. Peng, and Z. Zhang, “Incidence of Venous Thromboembolism During Pregnancy and the Puerperium: A Systematic Review and Meta-Analysis,” Journal of Maternal-Fetal & Neonatal Medicine 28 (2015): 245–253.

[4]

X. Luo, D. Shan, L. Zhang, et al., “Incidence of Maternal Venous Thromboembolism in China: A Systematic Review and Meta-Analysis,” International Journal of Gynaecology and Obstetrics 163, no. 1 (2023): 75–88.

[5]

X. Wang, S. Chen, H. Xu, R. Zhang, and T. Zhan, “Trend, Clinical Characteristics, and Pregnancy Outcomes of Pregnancy Associated Venous Thromboembolism: A Retrospective Analysis of Nearly 10 Years,” Journal of Maternal-Fetal & Neonatal Medicine 38 (2025): 2448504.

[6]

K. Miyamoto, H. Komatsu, K. Yamamoto, et al., “Risk Factors for Venous Thromboembolism in Pregnant Women in Japan: A Retrospective Study,” Journal of Maternal-Fetal & Neonatal Medicine 38, no. 1 (2025): 2551645.

[7]

Z. Yang, H. Zhao, M. Zhang, H. Xiang, H. Tu, and F. Sun, “Revisiting Real-World Data Studies: Progress, Value, and Challenges,” Innovation Medicine 3 (2025): 100143.

[8]

F. E. Hytten, T. Lind, and A. M. Thomson, “Calcium Balance in Pregnancy,” Lancet 2 (1974): 1152.

[9]

G. Khattar, F. S. Siddiqui, R. Grovu, et al., “The Calcium-Clot Connection: Investigating the Association Between Primary Hyperparathyroidism and Acute Venous Thromboembolism,” Journal of Thrombosis and Thrombolysis 57 (2024): 220–225.

[10]

O. Sahota, “Reducing the Risk of Fractures With Calcium and Vitamin D,” Bmj 340 (2010): b5492.

[11]

G. Falck, H. Lundgaard, T. Jareld, et al., “Effect of Magnesium Infusion on Bleeding Time in Healthy Male Volunteers,” Scandinavian Journal of Clinical and Laboratory Investigation 59 (1999): 425–430.

[12]

J. R. Sheu, G. Hsiao, M. Y. Shen, et al., “Mechanisms Involved in the Antiplatelet Activity of Magnesium in Human Platelets,” British Journal of Haematology 119 (2002): 1033–1041.

[13]

G. Bourjeily, M. Paidas, H. Khalil, K. Rosene-Montella, and M. Rodger, “Pulmonary Embolism in Pregnancy,” Lancet 375 (2010): 500–512.

[14]

N. Hu and R. McLean, “Lowering Sodium Intake: Reduction and Substitution for Cardiovascular Health,” International Journal for Vitamin and Nutrition Research 95, no. 3 (2025): 36289.

[15]

H. Castro and L. Raij, “Potassium in Hypertension and Cardiovascular Disease,” Seminars in Nephrology 33 (2013): 277–289.

[16]

B. A. Willems, M. Furmanik, M. M. J. Caron, et al., “Ucma/GRP Inhibits Phosphate-Induced Vascular Smooth Muscle Cell Calcification via SMAD-Dependent BMP Signalling,” Scientific Reports 8 (2018): 4961.

[17]

P. Düsing, A. Zietzer, P. R. Goody, et al., “Vascular Pathologies in Chronic Kidney Disease: Pathophysiological Mechanisms and Novel Therapeutic Approaches,” Journal of Molecular Medicine 99 (2021): 335–348.

[18]

D. Dedinszki, F. Szeri, E. Kozák, et al., “Oral Administration of Pyrophosphate Inhibits Connective Tissue Calcification,” EMBO Molecular Medicine 9 (2017): 1463–1470.

[19]

A. Ahmed, “Fetomaternal Acid–Base Balance and Electrolytes During Pregnancy,” Indian Journal of Critical Care Medicine 25 (2021): S193–S199.

[20]

G. Lerstad, E. E. Brodin, J. Svartberg, et al., “Associations Between Serum Levels of Calcium, Parathyroid Hormone and Future Risk of Venous Thromboembolism: The Tromso Study,” European Journal of Endocrinology 176 (2017): 625–634.

[21]

M. Blondon, R. J. Rodabough, N. Budrys, et al., “The Effect of Calcium Plus Vitamin D Supplementation on the Risk of Venous Thromboembolism. From the Women's Health Initiative Randomized Controlled Trial,” Thrombosis and Haemostasis 113 (2015): 999–1009.

[22]

S. K. Kunutsor and J. A. Laukkanen, “Circulating Serum Magnesium and the Risk of Venous Thromboembolism in Men: A Long-Term Prospective Cohort Study,” Pulse 8 (2021): 108–113.

[23]

J. Yu, H. Su, S. Wei, F. Chen, and C. Liu, “Calcium Content Mediated Hemostasis of Calcium-Modified Oxidized Microporous Starch,” Journal of Biomaterials Science, Polymer Edition 29 (2018): 1716–1728.

[24]

M. Li, J. Roeder, J. Blázquez-Prieto, et al., “Calcium-Activated Potassium Channels as Amplifiers of TRPV4-Mediated Pulmonary Edema Formation in Male Mice,” Anesthesiology 141 (2024): 913–928.

[25]

D. F. Waugh and J. N. Lindon, “Effects of Ions on ADP-Induced Aggregation of Bovine or Human Platelets,” Thrombosis and Haemostasis 36 (1976): 465–478.

[26]

S. Huang, H. Li, L. Zhang, H. Chen, and C. Gao, “Global Burden of Diseases Associated With Iron Deficiency: GBD 2021,” International Journal for Vitamin and Nutrition Research 95 (2025): 31351.

[27]

Q. Xu, C. Zhu, L. Li, J. Li, Z. An, and C. Tang, “The Role of Ferroptosis in Women's Health and Diseases,” MedComm 6, no. 8 (2025): e70296.

[28]

Y. Mei, X. Wang, H. Xu, et al., “Cardiovascular Diseases Burden Attributable to Dietary Risk Factors in 204 Countries and Territories,” Innovation Nutrition 1, no. 1 (2026): 100015.

[29]

J. Zhang, T. Geng, Y. Wang, et al., “Challenges, Advances and Future Directions in Nutritional Epidemiology,” Innovation Nutrition 1, no. 1 (2026): 100009.

[30]

Q. Li, G. Zhang, X. Li, et al., “Risk of Cardiovascular Disease Among Cancer Survivors: Systematic Review and Meta-Analysis,” EClinicalMedicine 84 (2025): 103274.

[31]

Q. Li, X. Li, W. Zhai, et al., “U-Shaped Association of Third-Trimester Serum Uric Acid With Postpartum Hemorrhage: Statistical Mediation Effects of Hemoglobin, Fibrinogen, and D-Dimer—A Multicenter Cohort Study,” Thrombosis and Haemostasis (2026), Epub ahead of print.

[32]

H. Hayssen, R. Cires-Drouet, B. Englum, et al., “Systematic Review of Venous Thromboembolism Risk Categories Derived From Caprini Score,” Journal of Vascular Surgery: Venous and Lymphatic Disorders 10 (2022): 1401–1409.e7.

[33]

G. Feng, H. Xu, S. Wan, et al., “Twelve Practical Recommendations for Developing and Applying Clinical Predictive Models,” Innovation Medicine 2, no. 4 (2024): 100105.

[34]

I. M. Van Schouwenburg, B. K. Mahmoodi, N. J. Veeger, et al., “Insulin Resistance and Risk of Venous Thromboembolism: Results of a Population-Based Cohort Study,” Journal of Thrombosis and Haemostasis 10 (2012): 1012–1018.

[35]

J. S. Gerber, E. M. P. Arroyo, J. Pastor, et al., “Controlled Dietary Phosphate Loading in Healthy Young Men Elevates Plasma Phosphate and FGF23 Levels,” Pflugers Archiv: European Journal of Physiology 477 (2025): 495–508.

[36]

L. V. Tang, P. E. Morange, J. Corral, et al., “Practical Guideline for Major Hereditary Thrombophilia,” Innovation 6 (2025): 100890.

[37]

Q. Li, H. Wang, H. Wang, et al., “Association Between Serum Alkaline Phosphatase Levels in Late Pregnancy and the Incidence of Venous Thromboembolism Postpartum: A Retrospective Cohort Study,” EClinicalMedicine 62 (2023): 102088.

[38]

Q. Li, H. Wang, H. Wang, et al., “Associations of Blood Pressure in the Third Trimester and Risk of Venous Thromboembolism Postpartum,” MedComm 5 (2024): e619.

[39]

S. G. Albert and T. Scott Isbell, “Reconsideration of “Albumin Corrected Total Calcium” Determinations: Potential Errors in the Clinical Management of Disorders of Calcium Metabolism,” Clinica Chimica Acta 544 (2023): 117353.

[40]

J. C. Tremblay, R. L. Hoiland, C. A. Howe, et al., “Global REACH 2018: High Blood Viscosity and Hemoglobin Concentration Contribute to Reduced Flow-Mediated Dilation in High-altitude Excessive Erythrocytosis,” Hypertension 73, no. 6 (2019): 1327–1335.

[41]

D. Fan, V. Lanting, E. Camilleri, M. H. A. Bos, A. M. R. Rondon, and H. H. Versteeg, “Coagulation Parameters in Gastrointestinal Cancer Patients With Venous Thromboembolism,” Thrombosis Research 258 (2026): 109587.

[42]

A. J. Darzi, S. G. Karam, R. Charide, et al., “Prognostic Factors for VTE and Bleeding in Hospitalized Medical Patients: A Systematic Review and Meta-Analysis,” Blood 135, no. 20 (2020): 1788–1810.

[43]

J. F. Bobb, B. Claus Henn, L. Valeri, and B. A. Coull, “Statistical Software for Analyzing the Health Effects of Multiple Concurrent Exposures via Bayesian Kernel Machine Regression,” Environmental Health 17 (2018): 67.

Rights & permissions

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

PDF (1683KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉